327 related articles for article (PubMed ID: 27381850)
21. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
[TBL] [Abstract][Full Text] [Related]
22. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
[TBL] [Abstract][Full Text] [Related]
23. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
[TBL] [Abstract][Full Text] [Related]
24. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders.
van den Berg MMJ; Krauskopf J; Ramaekers JG; Kleinjans JCS; Prickaerts J; Briedé JJ
Prog Neurobiol; 2020 Feb; 185():101732. PubMed ID: 31816349
[TBL] [Abstract][Full Text] [Related]
25. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
[TBL] [Abstract][Full Text] [Related]
26. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
28. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
Wang J; Chen C; Zhang Y
J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
[TBL] [Abstract][Full Text] [Related]
29. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044
[TBL] [Abstract][Full Text] [Related]
30. Circulating Biomarker Panels in Alzheimer's Disease.
Zafari S; Backes C; Meese E; Keller A
Gerontology; 2015; 61(6):497-503. PubMed ID: 25720553
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
Blennow K; Biscetti L; Eusebi P; Parnetti L
Mov Disord; 2016 Jun; 31(6):836-47. PubMed ID: 27145480
[TBL] [Abstract][Full Text] [Related]
32. Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases.
Mayo S; Benito-León J; Peña-Bautista C; Baquero M; Cháfer-Pericás C
Curr Neuropharmacol; 2021; 19(8):1273-1303. PubMed ID: 33357195
[TBL] [Abstract][Full Text] [Related]
33. Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum.
Ruf WP; Freischmidt A; Grozdanov V; Roth V; Brockmann SJ; Mollenhauer B; Martin D; Haslinger B; Fundel-Clemens K; Otto M; Arnim CV; Holzmann K; Ludolph AC; Weishaupt JH; Danzer KM
Cells; 2021 Apr; 10(4):. PubMed ID: 33918274
[TBL] [Abstract][Full Text] [Related]
34. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
35. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
[TBL] [Abstract][Full Text] [Related]
36. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.
Jin XF; Wu N; Wang L; Li J
Cell Mol Neurobiol; 2013 Jul; 33(5):601-13. PubMed ID: 23633081
[TBL] [Abstract][Full Text] [Related]
37. Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson's disease patients.
Qin LX; Tan JQ; Zhang HN; Tang JG; Jiang B; Shen XM; Tang BS; Wang CY
J Clin Neurosci; 2019 Dec; 70():198-201. PubMed ID: 31492481
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
Leuenberger N; Saugy M
Adv Exp Med Biol; 2015; 888():401-8. PubMed ID: 26663194
[TBL] [Abstract][Full Text] [Related]
39. Common microRNA regulated pathways in Alzheimer's and Parkinson's disease.
Awuson-David B; Williams AC; Wright B; Hill LJ; Di Pietro V
Front Neurosci; 2023; 17():1228927. PubMed ID: 37719162
[TBL] [Abstract][Full Text] [Related]
40. Circulating miRNAs as biomarkers for neurodegenerative disorders.
Grasso M; Piscopo P; Confaloni A; Denti MA
Molecules; 2014 May; 19(5):6891-910. PubMed ID: 24858274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
